OPKO Health, Inc. (OPK)
1.555
-0.02
(-0.96%)
USD |
NASDAQ |
Sep 14, 16:00
1.555
0.00 (0.00%)
After-Hours: 16:32
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.160B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 9.79% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 2.023 |
| Price to Book Value | 0.9796 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.3362 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 85.55% |
Profile
| OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment manages the clinical laboratory operations of BioReference. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and their global pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL. |
| URL | http://www.opko.com |
| Investor Relations URL | https://www.opko.com/investors |
| HQ State/Province | Florida |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Equity Style | Small Cap Value |
| Next Earnings Release | Oct. 28, 2026 (est.) |
| Last Earnings Release | Jul. 27, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment manages the clinical laboratory operations of BioReference. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and their global pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL. |
| URL | http://www.opko.com |
| Investor Relations URL | https://www.opko.com/investors |
| HQ State/Province | Florida |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Equity Style | Small Cap Value |
| Next Earnings Release | Oct. 28, 2026 (est.) |
| Last Earnings Release | Jul. 27, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |